Literature DB >> 31038470

Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1.

Bahir H Chamseddin1, La'Nette Hernandez1, Dezehree Solorzano1, Juan Vega1, Lu Q Le1,2,3.   

Abstract

BACKGROUND: Cutaneous neurofibromas (cNF) are physically disfiguring, painful, and cause extensive psychologic harm in patients with neurofibromatosis type 1 (NF1). There is currently no effective medical treatment and surgical procedures are inaccessible to most NF1 patients globally.
OBJECTIVE: While research is underway to find an effective medical treatment for cNF, there is an urgent need to develop surgical approach that is accessible to all NF1 patients in the world with the skill set and equipment found in most general medical office settings. Here, we present a robust surgical approach to remove cNF that does not require sterile surgical field, utilizes accessible clinical equipment, and can be performed by any health care providers including family practitioners, and physician assistants.
METHODS: In a prospective case-series, patients with NF1 underwent this surgical procedure which removes multiple cutaneous neurofibromas. The Dermatology Life Quality Index was given to subjects before and after the procedure as surrogate for patient satisfaction.
RESULTS: 83 tumors were removed throughout the body from twelve individuals. Examination at follow-up visits revealed well-healed scars without infection or adverse events including aberrant scarring. Patient satisfaction with the procedure was high with significant improvements in symptoms, daily activities, leisure, personal relationships, and treatment experience (P = 0.00062).
CONCLUSION: This study demonstrates a robust surgical approach to management cutaneous neurofibromas which can be accessed world-wide to individuals with NF1 and performed by a wide-variety of medical specialists with high clinical efficacy and patient satisfaction.

Entities:  

Keywords:  Dermatology; Neuroscience; Tumor suppressors

Year:  2019        PMID: 31038470      PMCID: PMC6629109          DOI: 10.1172/jci.insight.128881

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  33 in total

Review 1.  10 years experience of the Dermatology Life Quality Index (DLQI).

Authors:  Victoria Lewis; Andrew Y Finlay
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

Review 2.  Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management.

Authors:  Bolaji O Mofikoya; Wasiu L Adeyemo; Abbas A Abdus-salam
Journal:  Nig Q J Hosp Med       Date:  2007 Oct-Dec

Review 3.  Using tissue adhesive for wound repair: a practical guide to dermabond.

Authors:  T B Bruns; J M Worthington
Journal:  Am Fam Physician       Date:  2000-03-01       Impact factor: 3.292

Review 4.  A comprehensive review of epinephrine in the finger: to do or not to do.

Authors:  K Denkler
Journal:  Plast Reconstr Surg       Date:  2001-07       Impact factor: 4.730

Review 5.  Digital anesthesia with epinephrine: an old myth revisited.

Authors:  Aleksandar L Krunic; Linda C Wang; Keyoumars Soltani; Sarah Weitzul; R Stan Taylor
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

Review 6.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

7.  Hypertrophic scars after therapy with CO2 laser for treatment of multiple cutaneous neurofibromas.

Authors:  J U Ostertag; C C W Theunissen; H A M Neumann
Journal:  Dermatol Surg       Date:  2002-03       Impact factor: 3.398

8.  Use of the carbon dioxide laser in treating multiple cutaneous neurofibromas.

Authors:  D W Becker
Journal:  Ann Plast Surg       Date:  1991-06       Impact factor: 1.539

9.  Electrosurgical excision technique for the treatment of multiple cutaneous lesions in neurofibromatosis type I.

Authors:  Steven M Levine; Elie Levine; Peter J Taub; Hubert Weinberg
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-05-25       Impact factor: 2.740

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  3 in total

1.  The Number of Surgical Interventions and Specialists Involved in the Management of Patients with Neurofibromatosis Type I: A 25-Year Analysis.

Authors:  Chih-Kai Hsu; Rafael Denadai; Chun-Shin Chang; Chuan-Fong Yao; Ying-An Chen; Pang-Yun Chou; Lun-Jou Lo; Yu-Ray Chen
Journal:  J Pers Med       Date:  2022-04-01

2.  Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.

Authors:  Jean-Philippe Brosseau; Adwait A Sathe; Yong Wang; Toan Nguyen; Donald A Glass; Chao Xing; Lu Q Le
Journal:  Acta Neuropathol Commun       Date:  2021-01-07       Impact factor: 7.801

3.  Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.

Authors:  Juan Mo; Corina Anastasaki; Zhiguo Chen; Tracey Shipman; Jason Papke; Kevin Yin; David H Gutmann; Lu Q Le
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.